This federal contract award, valued at $8,511.90, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4566594786 - VALSARTAN-HCTZ 80-12.5 MG TAB 90S, a cardiovascular medication, with a completion date of December 4, 2024.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
This contract award was not designated with a set-aside requirement, indicating open competition. As a major supplier of pharmaceutical and medical products to federal agencies, Amerisourcebergen plays a critical role in supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries through its extensive distribution capabilities and government contracting vehicles.
Generated 3/4/25, 11:38 AM